Glycobiology and Drug Design

Informationen zum Autor Anatole Klyosov is the Chief Scientist and Founder of Galectin Therapeutics. Klappentext Will update existing publications on carbohydrate-based drug design and further shape the emerging data and thinking in this new area. Zusammenfassung Will update existing publications on carbohydrate-based drug design and further shape the emerging data and thinking in this new area.

Dettagli sul prodotto

• Autori: Anatole A. Klyosov, Anatole A. (EDT) Klyosov
• Con la collaborazione di: Anatole A. Klyosov (Editore), Anatole A. (Galectin Therapeutics) Klyosov (Editore), Klyosov Anatole A. (Editore)
• Editore: Oxford University Press
• Lingue: Inglese
• Formato: Copertina rigida
• Pubblicazione: 08.02.2013
• EAN: 9780841227651
• ISBN: 978-0-8412-2765-1
• Pagine: 344
• Serie: ACS Symposium Series; ACS Symposium
• Categorie: Scienze naturali, medicina, informatica, tecnica > Medicina > Farmacia; SCIENCE / Life Sciences / Biochemistry, MEDICAL / Pharmacology, biochemistry, Pharmacology